Navigation Links
Chindex International, Inc. Announces Results for the Quarter and Nine Months Ended December 31, 2007
Date:2/8/2008

f $3,640 and $2,827,

respectively

Product sales receivables 13,697 13,133

Patient service receivables 7,686 6,104

Inventories 9,800 7,835

Deferred income taxes 3,659 2,463

Other current assets 3,682 3,153

Total current assets 96,522 43,384

Property and equipment, net 17,342 18,482

Long-term deferred income taxes 95 607

Other assets 1,156 434

Total assets $115,115 $62,907

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable and accrued expenses $26,092 $22,877

Short-term portion of capitalized leases 33 36

Short-term debt and vendor financing 1,038 2,710

Income taxes payable 2,142 629

Total current liabilities 29,305 26,252

Long-term portion of capitalized leases 33 58

Long-term debt and vendor financing 36,594 8,679

Total liabilities 65,932 34,989

Commitments and contingencies

Stockholders' equity:

Preferred stock, $.01 par value, 500,000 shares

authorized, none issued 0 0

Common stock, $.01 par value, 28,200,000 shares

authorized, including 3,200,000 designated Class B:

Common stock - 7,151,011 and 6,332,345 shares

issued and outstanding at December 31, 2007

an
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
2. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
3. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
4. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
5. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
6. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
7. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
8. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
9. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
10. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
11. Natural Alternatives International, Inc. Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...veloped a new method for screening drug-resistance...r. Frederic D. Bushman, Professor of Microbiology ...ne, combined two genetic tests, which enabled him ...nces from multiple drug-resistant HIV samples at o...
...hier lifestyle in middle age lowers the risk of ca...al University of South Carolina, Charleston found ...k up healthy lifestyle behaviours, could considera...lar disease (CVD) and reduce their death rate. &...
... of infants against H. influenzae type b (Hib), a ...ingitis, could save innumerable children in Asia. ...line in The Pediatric Infectious Disease Journal, ...ation of infants with a Hib conjugate vaccine prev...
...coholism (NIAAA), a part of the U.S. National Inst...ct subtypes of alcoholism by analysing a national...ndence. Our findings should help dispel the popul...notes first author Dr. Howard B. Moss, NIAAA Assoc...
Other Medicine News:Health News:Highly Effective Method for Screening Drug-resistant Forms of HIV Developed 2Health News:Adopting Healthy Lifestyle in Middle Age Lowers Heart Disease Risk 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 3Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 2Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 3
(Date:7/23/2008)...publication in July print edition of Clinical ...IANAPOLIS, July 23 /- A Roche Diagnos...-terminal pro-B-type natriuretic peptide,(NT-proBN...isk,stratification in predicting the risk of cardi...ed with non-steroidal anti-inflammatory drugs of,t...
(Date:7/23/2008)...Areas of the Body Have Greater Concentrations of,S...wswire-USNewswire/ -- Fat removed,from the lower a...nd to be,an excellent source of stem cells, with h... the body, reports a Brazilian-based study in Augu...ficial medical journal of the,American Society of ...
(Date:7/22/2008)...uly 22 /- Following a,thoro...d of Progen,Pharmaceuticals Limited (ASX: PGL; Nas...d the PI-88 phase 3 study in liver cancer. Progen ...xisting portfolio of compounds and,the company wil...d,opportunities through Merger & Acquisition activ...
(Date:7/22/2008)...uss Development Plan Completed Successfully, DUBL...rin Corporation,plc (NASDAQ: AMRN ) today announc... the U.S. Food and Drug Administration (FDA) to di...e treatment of,hypertriglyceridemia. Following the... 3 with AMR101 in hypertriglyceridemia., Dr. Decl...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 1Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 2Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 4Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 1Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 2Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 1Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 1China Bio Energy Reports Fiscal 2007 Financial Results 4324 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 3China Bio Energy Reports Fiscal 2007 Financial Results 4324 4China Bio Energy Reports Fiscal 2007 Financial Results 4324 5China Bio Energy Reports Fiscal 2007 Financial Results 4324 6China Bio Energy Reports Fiscal 2007 Financial Results 4324 7China Bio Energy Reports Fiscal 2007 Financial Results 4324 8China Bio Energy Reports Fiscal 2007 Financial Results 4324 9China Bio Energy Reports Fiscal 2007 Financial Results 4324 10China Bio Energy Reports Fiscal 2007 Financial Results 4324 11
...s Efficacy at Improving Glycemic Control and,Reduc..., Ill., June 23, 2007 /PRNewswire/ -- VeroScience,...rtner S2 Therapeutics,Inc., reported today the re...the overall and cardiovascular safety of Cycloset(...mesylate) in subjects,with type 2 diabetes. The st...
...--Jun 25, 2007 - HepaLife Technologies, Inc.,(OTCB...that new,data presented at an international influe...,s patented PBS-1 cell line outperforms,current ce...us,inside its cells. The most important step towar...against a targeted virus is the,ability to efficie...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6
...y Biotech Captia™ Varicella- Zoster Virus (VZV...s intended for the detection and quantitative dete...dividual serum specimens may be used for the deter...convalescent, may be used to demonstrate seroconve...
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as
The Trinity Biotech Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative detection of IgM antibody in human serum to Mumps for the determination of immunological experi
The DIAGNOSTIC AUTOMATION, INC. (DAI) Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Mumps virus in human sera. In
Medicine Products: